IP Verse

Pharmaceutical Formulations Containing Rifaximin, Processes For Their Obtainment And Method Of Treating Intestinal Disease - EP2618819

PATENT ANALYSIS

Patent Details

Grant Date
Nov 1, 2017
Company
ALFASIGMA S.P.A.
Oppositions

SANDOZ GMBH

More patents of Alfasigma S.P.A.

EP3439637

EP2618819

EP2560662

Want to monitor this patent?

Feel free to send us a message here and we will get back to you